TP53 and neoplasm: Mutations or deletions of TP53 occur for more than half of all CRCs, particularlyin patients at the more advanced stages.3 Upon abnormal p53 expression during tumor progression, other p53-relatedgenes as those coding for some ribosomal proteins (RPs) are also outof control and have been identified as cancer-related molecules.4,5